Is INZY or RYLD a better dividend investment in 2026?

INZY currently yields 50.00% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: INZY offers higher current income.

What is the dividend yield difference between INZY and RYLD?

INZY has a forward dividend yield of 50.00% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 37.86 percentage points.

Home › Compare › INZY vs RYLD

INZY vs RYLD: Dividend Comparison 2026

INZY yields 50.00% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 INZY wins by $349.5K in total portfolio value

INVESTMENT

TIME HORIZON10 years

INZY

● Live price

50.00%

Share price

$4.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$394.0K

Annual income

$79,849.97

Full INZY calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — INZY vs RYLD

📍 INZY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	INZY	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, INZY + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

INZY pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

INZY

Annual income on $10K today (after 15% tax)

$4,250.00/yr

After 10yr DRIP, annual income (after tax)

$67,872.47/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, INZY beats the other by $65,673.23/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of INZY + RYLD for your $10,000?

INZY: 50%RYLD: 50%

100% RYLD50/50100% INZY

Portfolio after 10yr

$219.3K

Annual income

$41,218.65/yr

Blended yield

18.80%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on INZY right now

INZY

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$12.00

+200.0% upside vs current

Range: $4.00 — $16.00

Altman Z

-6.5

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

INZY buys

RYLD buys

No recent congressional trades found for INZY or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricINZYRYLD

Forward yield	50.00% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$394.0K ✓	$44.5K
Annual income after 10y	$79,849.97 ✓	$2,587.35
Total dividends collected	$314.4K ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: INZY vs RYLD ($10,000, DRIP)

Year	INZY Portfolio	INZY Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$15,700	$5,000.00	$11,914	$1,213.65	+$3.8K → INZY
2	$24,135	$7,336.45	$14,099	$1,351.30	+$10.0K → INZY
3	$36,365	$10,540.42	$16,580	$1,494.55	+$19.8K → INZY
4	$53,753	$14,842.48	$19,384	$1,642.61	+$34.4K → INZY
5	$78,020	$20,504.11	$22,535	$1,794.70	+$55.5K → INZY
6	$111,295	$27,813.68	$26,063	$1,950.00	+$85.2K → INZY
7	$156,166	$37,080.39	$29,995	$2,107.69	+$126.2K → INZY
8	$215,724	$48,626.29	$34,361	$2,266.99	+$181.4K → INZY
9	$293,602	$62,776.77	$39,194	$2,427.12	+$254.4K → INZY
10	$394,004	$79,849.97	$44,525	$2,587.35	+$349.5K → INZY

INZY vs RYLD: Complete Analysis 2026

INZY — Stock

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Full INZY Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this INZY vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

INZY vs SCHD INZY vs JEPI INZY vs O INZY vs KO INZY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.